Laxbene Für Kinder Ab 8 Jahren Und Erwachsene (Macrogol 4000)

Macrogol 4000 is a high‑molecular‑weight polyethylene glycol that remains in the gastrointestinal tract without systemic absorption. It binds water molecules, creating an osmotic gradient that increases the fluid content of the intestinal lumen. The resulting softer stool and expanded luminal volume stimulate peristalsis, promoting regular evacuation.

The dosage of Laxbene is individualized; the prescribing healthcare professional determines the appropriate amount based on the patient’s age, weight, severity of constipation, and response to therapy. Patients should follow the prescriber’s instructions and the product label, and any dose adjustments should be made only under medical supervision.

Safety data for macrogol 4000 in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider. Women who are pregnant or nursing should discuss alternatives and appropriate monitoring with their doctor.

To place an order, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and assistance with import documentation.

Compared with stimulant laxatives, macrogol 4000 acts osmotically, softening stool without stimulating intestinal muscles, which often results in fewer cramping side effects. Unlike stimulant agents, it is generally better tolerated for long‑term use. It is similar in effect to other polyethylene glycol formulations but may differ in dosing convenience and excipient composition.

Laxbene should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture, direct sunlight, and excessive heat. Do not freeze the medication, and ensure the packaging remains sealed until use to maintain product stability.

Laxbene is taken orally, usually dissolved in a measured amount of water or another suitable liquid as directed by the prescriber. The solution should be consumed promptly after preparation. Patients should drink an adequate amount of fluids throughout the day to support the laxative effect and prevent dehydration.

The most serious risks include severe electrolyte disturbances, particularly hyponatremia or hypokalemia, which can occur with excessive dosing or prolonged use. Allergic reactions such as rash, swelling, or breathing difficulty, and signs of intestinal obstruction like persistent abdominal pain or vomiting, also require immediate medical attention.

Laxbene is contraindicated in individuals with known hypersensitivity to macrogol or any of its excipients, in patients with complete bowel obstruction, perforated gastrointestinal tract, or severe inflammatory bowel disease. Caution is advised for those with renal impairment, severe dehydration, or electrolyte imbalances, and it should be avoided unless supervised by a healthcare professional.